Log In
Print
BCIQ
Print
Print this Print this
 

ALD-401

  Manage Alerts
Collapse Summary General Information
Company Cytomedix Inc.
DescriptionStem cells derived from bone marrow expressing high levels of aldehyde dehydrogenase
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase II
Standard IndicationStroke
Indication DetailsTreat ischemic stroke
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today